Financial Advocates Investment Management’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,385
Closed -$240K 764
2024
Q1
$240K Buy
6,385
+27
+0.4% +$965 0.01% 670
2023
Q4
$228K Buy
6,358
+45
+0.7% +$1.73K 0.01% 653
2023
Q3
$239K Sell
6,313
-886
-12% -$36.1K 0.02% 597
2023
Q2
$293K Buy
7,199
+28
+0.4% +$1.16K 0.02% 527
2023
Q1
$300K Buy
7,171
+1,980
+38% +$82.5K 0.02% 557
2022
Q4
$224K Sell
5,191
-374
-7% -$14.8K 0.02% 646
2022
Q3
$208K Sell
5,565
-31,368
-85% -$1.39M 0.02% 673
2022
Q2
$1.67M Buy
36,933
+31,624
+596% +$1.49M 0.14% 187
2022
Q1
$253K Sell
5,309
-2,168
-29% -$91.8K 0.02% 622
2021
Q4
$308K Buy
7,477
+102
+1% +$3.84K 0.02% 628
2021
Q3
$254K Buy
7,375
+2
+0% +$68 0.02% 645
2021
Q2
$233K Sell
7,373
-293
-4% -$9.43K 0.02% 664
2021
Q1
$212K Buy
7,666
+548
+8% +$16.5K 0.02% 702
2020
Q4
$214K Buy
+7,118
New +$210K 0.01% 664

Other funds holding EXC

Financial Advocates Investment Management's EXC Position: Q2 2024 in Review

Financial Advocates Investment Management sold out of Exelon (EXC) in Q2 2024, closing a stake of 6,385 shares — an estimated $240K sold.

Financial Advocates Investment Management first reported a position in EXC in Q4 2020 and held it in 14 quarters. The position peaked at $1.67M in Q2 2022. 990 funds tracked by Wall St. Rank hold EXC as of Q2 2024.

  • Financial Advocates Investment Management reported no remaining Exelon position as of Q2 2024 after selling out during the quarter.
  • Financial Advocates Investment Management sold 6,385 Exelon shares in Q2 2024, an estimated $240K.
  • Financial Advocates Investment Management first reported a position in Exelon in Q4 2020 and held it in 14 quarters.
  • Financial Advocates Investment Management's Exelon position peaked at $1.67M in Q2 2022.
  • 990 funds tracked by Wall St. Rank held Exelon as of Q2 2024.

Based on Financial Advocates Investment Management's 13F filing for Q2 2024, filed 29 Jul 2024.